Denk Pharma to Attend ESC Congress in Madrid with International Cardiology Experts

Press Release
Munich/Madrid, 08 August 2025 – Denk Pharma is pleased to announce that it will be attending the European Society of Cardiology (ESC) Congress 2025 in Madrid, Spain, from 29 August to 1 September. As part of our commitment to advancing cardiovascular care worldwide, 75 international cardiology experts from Denk Pharma’s global medical network will join the leading cardiology event.
Alessandra Knorr
Corporate Communications

Dr. Fernando Guzman, Head of Medical Affairs, will represent Denk Pharma on site, accompanied by his expert team. They will actively engage in key scientific sessions, collect the latest developments in cardiovascular research, therapies and clinical practice. The findings and insights gathered will be consolidated into a comprehensive post-congress brochure designed to facilitate the transfer of medical knowledge within our professional community.

At Denk Pharma, we see the ESC Congress as a unique opportunity to elevate global standards in cardiology through informed exchange,’ says Dr. Fernando Guzman, Head of Medical Affairs at Denk Pharma. ‘With our international presence and medical expertise, we’re well positioned to support physicians and partners in applying the most recent clinical evidence in their local practice.

To encourage more in-depth discussions within the medical community, you can schedule appointments with our medical team in advance. This initiative underlines Denk Pharma’s ongoing efforts to encourage collaborative knowledge sharing and scientific engagement across borders.

In addition to providing live updates, Denk Pharma will showcase highlights from key presentations, emerging therapies and clinical trial results throughout the event on its website, social media channels and the digital hub. The Quality meets Expertise Hub is a dedicated platform offering exclusive webinars by leading physicians as well as easily accessible insights, including the latest clinical studies available for download. Enter via: https://www.denkpharma.com/qualitymeetsexpertise.

For press inquiries, expert interviews, or to arrange a meeting with our delegation in Madrid, please contact:

Alessandra Knorr
Corporate Communications
+49 89 230 67 0
presse@denkpharma.de
Denk Pharma GmbH & Co. KG
www.denkpharma.com

About Denk Pharma
Denk Pharma is a German pharmaceutical company focused on the international export of premium-quality medicines. For over 75 years, the Denk Pharma name has stood for trusted pharmaceuticals “Made in Germany”, distributed in more than 80 countries worldwide. We are committed to strict treatment standards for the health of our patients, therefore our products are manufactured according to rigorous GMP (Good Manufacturing Practice) guidelines, undergo stringent quality testing, and are continuously monitored to meet international safety and efficacy requirements.

Denk Pharma News
Share this post

Denk Pharma

You are now leaving the English version of our website. This link will take you to the newly selected language version. The content of these pages may differ accordingly.

Note on the product portfolio

Please also note that some of the products shown are only available in selected regions. Please enquire about product availability in your region.